Monopar reports positive Phase 2 results for Wilson disease drug ALXN1840
Filed May 19, 2026 · Period ending May 19, 2026 · ~1 min read
2 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade MNPR commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 1, 2026 5:44 AM